Press release
Global Anticonvulsants Market 2023 Future Outlook, Industry Trends, Growth Rate And Forecast To 2032 | Major Players Are Eisai Co Ltd., GSK plc, Pfizer Inc., Johnson & Johnson Services Inc., Novartis AG
Anticonvulsants Market
The Business Research Company's Anticonvulsants Global Market Report 2023 identifies rise in the prevalence of epilepsy as the major driver for the Anticonvulsants Market's growth in the forecast period. Epilepsy is a common disorder that affects the brain and frequently results in seizures. It is a chronic nontransmissible disease of the brain that affects people of all ages. Anticonvulsants are medications used to suppress seizures in people with epilepsy. Anticonvulsants help control symptoms of epilepsy by blocking the abnormal electrical activity in the brain that causes seizures and is not necessarily a cure for the disease.
The global anticonvulsants market size is expected to grow from $17.65 billion in 2022 to $18.39 billion in 2023 at a compound annual growth rate (CAGR) of 4.22%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global anticonvulsants market size is expected to reach $20.87 billion in 2027 at a CAGR of 3.2%.
Download Free Sample Of Anticonvulsants Market Report
https://www.thebusinessresearchcompany.com/sample.aspx?id=10682&type=smp
Major competitors in the Anticonvulsants Market are Eisai Co Ltd., GSK plc, Pfizer Inc., Johnson & Johnson Services Inc., Novartis AG, Jazz Pharmaceuticals Inc., UCB SA, Teva Pharmaceutical Industries Ltd., Sunovion Pharmaceuticals Inc., Sanofi SA, Zydus Lifesciences Ltd., Lupin Limited, Ratiopharm, Kannalife Inc., and Neuropathix Inc.
A key trend in the Anticonvulsants Market includes Product development. Major companies operating in the anticonvulsants market are focused on developing innovative products to strengthen their position and gain a competitive advantage. For instance, in December 2022, Lupin Limited, an India-based pharmaceutical company, launched an abbreviated new drug application, Rufinamide tablets USP, 200 mg and 400 mg, an anticonvulsant drug. Rufinamide is used with other medications to control seizures in people who have a severe form of epilepsy called Lennox-Gastaut syndrome, which begins during childhood and causes several types of seizures, behavioral disturbances, and developmental delays in an individual.
Read More On The Global Anticonvulsants Market Report Here:
https://www.thebusinessresearchcompany.com/report/anticonvulsants-global-market-report
The Anticonvulsants Market is segmented -
By Type: Pyrimidinediones, Benzodiazepines, Fructose Derivatives, Aromatic Allylic Alcohols, Valproylamides, Carboxamides, Bromides, Other Types
By Drug Generation: First Generation, Second Generation, Third Generation
By Dosage: Capsule, Tablet, Cream, Liquid, Rectal Gel, Other Dosages
By Application: Migraine, Epilepsy, Neuropathic Pain, Anxiety, Fibromyalgia, Bipolar Disorder, Borderline Personality Disorder
By End-User: Hospitals, Clinics, Other End-Users
By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Anticonvulsants Market.
The Business Research Company's "Global Anticonvulsants Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.
Explore Buying Options For The Anticonvulsants Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10682
The Table Of Content For The Anticonvulsants Market Include:
1. Executive Summary
2. Anticonvulsants Market Characteristics
3. Anticonvulsants Market Trends And Strategies
4. Anticonvulsants Market - Macro Economic Scenario
5. Anticonvulsants Market Size And Growth
……
26. Africa Anticonvulsants Market
27. Anticonvulsants Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Anticonvulsants Market
29. Anticonvulsants Market Future Outlook and Potential Analysis
30. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Anticonvulsants Market 2023 Future Outlook, Industry Trends, Growth Rate And Forecast To 2032 | Major Players Are Eisai Co Ltd., GSK plc, Pfizer Inc., Johnson & Johnson Services Inc., Novartis AG here
News-ID: 3163751 • Views: …
More Releases from The Business research company
Cast Resin Dry Type Transformer Market: Market Research Report on Market Size, G …
The cast resin dry type transformer market size has grown strongly in recent years. It will grow from $3.98 billion in 2023 to $4.28 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to the growth of urban areas and infrastructure development, increasing focus on energy efficiency and conservation, proliferation of data centers and it infrastructure,…
Construction Elastomers Market: Insights into Market Size, Growth Trends, and De …
The construction elastomers market size has grown strongly in recent years. It will grow from $5.79 billion in 2023 to $6.31 billion in 2024 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to urbanization, energy efficiency, weather resistance, sustainable construction, infrastructure development.
The construction elastomers market size is expected to see strong growth in the next few…
Commercial Aircraft Airframe Materials Market: Market Share, Growth Drivers, and …
The commercial aircraft airframe materials market size has grown rapidly in recent years. It will grow from $6.72 billion in 2023 to $7.48 billion in 2024 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to increased air traffic, increased travel and tourism, population growth, rise in disposable income, growth of the aviation industry .
The commercial aircraft airframe materials…
Chlor-Alkali Market Research Report: Market Size, Growth Trends, and Demand Fore …
The chlor-alkali market size has grown strongly in recent years. It will grow from $79.98 billion in 2023 to $86.26 billion in 2024 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to growth in chemical manufacturing, increased water treatment demand, growth of the pulp and paper industry, increased pharmaceutical production, and increased demand for food processing.
The chlor-alkali market…
More Releases for Anticonvulsants
Anticonvulsants Market Therapeutic Survey Reviews, Analysis 2025
The report titled “Anticonvulsants Market” report will be very useful to get a stronger and effective business outlook. It provides an in-depth analysis of different attributes of industries such as trends, SWOT analysis, policies, and clients operating in several regions. The qualitative and quantitative analysis techniques have been used by analysts to provide accurate and applicable data to the readers, business owners and industry experts.
The Anticonvulsants market was valued at…
Generic and branded anticonvulsants are restraining the growth of novel therapie …
Anticonvulsants, also commonly known as antiepileptic drugs or antiseizure drugs are a diverse group of pharmacology agents used in the treatment of epileptic seizures. Epilepsy is a chronic disorder resulting in repeated and unprovoked seizures. Epileptic seizures are commonly referred as convulsions. Anticonvulsants are mainly used for treatment of epileptic seizures. Epileptic seizures are caused by disturbance in the electrical activity of the brain. In addition, anticonvulsants are also used…
Anticonvulsants for Neuropathic Pain Market unprovoked by 2025
Global Anticonvulsants for Neuropathic Pain Market: Snapshot
Neuropathic pain, which refers to kind of chronic pain resulting from an injury to or disease of the central or peripheral nervous system, remains a therapeutic challenge to clinicians as it does not respond well to conventional pain therapies. Although the clinical knowledge regarding the pathogenesis of the condition has significantly increased over the past few decades, the actual mode of action of most…
Anticonvulsants Market Opportunities and Forecast Assessment,2016-2026
Anticonvulsants, also commonly known as antiepileptic drugs or antiseizure drugs are a diverse group of pharmacology agents used in the treatment of epileptic seizures. Epilepsy is a chronic disorder resulting in repeated and unprovoked seizures. Epileptic seizures are commonly referred as convulsions. Anticonvulsants are mainly used for treatment of epileptic seizures. Epileptic seizures are caused by disturbance in the electrical activity of the brain. In addition, anticonvulsants are also used…
Anticonvulsants Drug Market - Significant Growth During 2025
The first line of treatment in pain management usually involves the use of pharmaceuticals from various therapeutic classes such as antidepressants, opioids, NSAIDs, anticonvulsants, anesthetics, and other non-narcotic analgesics. Anticonvulsants, also known as antiepileptic drugs, were developed primarily for the treatment of epileptic seizures. However, leading anticonvulsant drugs such as Lyrica (pregabalin) and Neurontin (gabapentin) have also been approved for the management of various pain indications including fibromyalgia, migraine and…
Anticonvulsants Market Growth, Forecast and Value Chain 2016-2026
Anticonvulsants, also commonly known as antiepileptic drugs or antiseizure drugs are a diverse group of pharmacology agents used in the treatment of epileptic seizures. Epilepsy is a chronic disorder resulting in repeated and unprovoked seizures. Epileptic seizures are commonly referred as convulsions. Anticonvulsants are mainly used for treatment of epileptic seizures. Epileptic seizures are caused by disturbance in the electrical activity of the brain. In addition, anticonvulsants are also used…
